Free Trial

13 Stocks With Strong Institutional Buying - 8 of 13

 
 

Cencora (NYSE:COR)

Net Inflows of from Institutional Investors in Dollars
$9,855,956,018.00
Net Inflows of from Institutional Investors in Shares
43,956,633
Number of Institutional Transactions in the Last 90 Days
823

Inflows and Outflows by Quarter for Cencora (NYSE:COR)

Cencora logoCencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. Read More 
 
 

Get Ready for Next Week’s Elon Musk Shock (Ad)

I believe Elon Musk is about to shock the world again next week… When he’s set to unveil his new AI product. I’m hosting a special online strategy session to help you prepare on Monday at 10am ET.

Click here to see the details and save your seat.